Results 41 to 50 of about 124,582 (333)
Restenosis of Drug-Eluting Stents.
Circulation. Cardiovascular Interventions, 2019 Despite on-going evolution and iteration of drug-eluting stent (DES) technology, the prevalence of in-stent restenosis (ISR) remains relatively unchanged, encompassing ≈10% of percutaneous coronary interventions.
Evan Shlofmitz, M. Iantorno, R. Waksman
semanticscholar +1 more source
Journal of the American College of Cardiology, 2000 Restenosis is currently the major limitation of percutaneous transluminal coronary angioplasty (PTCA). Factors such as elastic recoil, migration of vascular smooth muscle cells from media to intima, neointimal proliferation and vascular remodeling underly the restenotic process. Presently there is no effective therapy available for restenosis. The role
Baskaran Chandrasekar +1 more
openaire +2 more sources
Prosthetic bypass for restenosis after endarterectomy or stenting of the carotid artery [PDF]
, 2017 OBJECTIVE: The objective of this study was to evaluate the results of prosthetic carotid bypass (PCB) with polytetrafluoroethylene (PTFE) grafts as an alternative to carotid endarterectomy (CEA) in treatment of restenosis after CEA or carotid artery ...
Belmonte, Romain +5 more
core +1 more source
Journal of Thoracic Disease, 2016 The lumen diameter reduction after percutaneous coronary intervention (PCI) is well known as "restenosis". This phenomenon is due to vessel remodeling/recoil in case of no-stent strategy or, in case of stent employ, "neointimal proliferation" that ...
D. Buccheri +3 more
semanticscholar +1 more source
Hyperhomocysteinemia and recurrent carotid stenosis
BMC Cardiovascular Disorders, 2008 Background Hyperhomocysteinemia has been identified as a potential risk for atherosclerotic disease in epidemiologic studies. This study investigates the impact of elevated serum homocysteine on restenosis after carotid endarterectomy (CEA). Methods In a
Liewald Florian +3 more
doaj +1 more source
European Heart Journal, 2015 Modern-day stenting procedures leverage advances in pharmacotherapy and device innovation. Patients treated with contemporary antiplatelet agents, peri-procedural antithrombin therapy and new-generation drug-eluting stents (DES) have excellent outcomes ...
R. Byrne, M. Joner, A. Kastrati
semanticscholar +1 more source
Cryoplasty for Arterial Restenosis [PDF]
European Journal of Vascular and Endovascular Surgery, 2007 A prospective follow-up study of patients with arterial restenosis undergoing cryoplasty.Between May 2004 and June 2005, 10 patients with restenosis following ilio-femoral endovascular treatment underwent twelve cryoplasty procedures. All patients had had at least one previous episode of stenosis treated by conventional endovascular methods and had ...
Jai V. Patel +6 more
openaire +2 more sources
Rupture of the arterial wall causes deflection in pressure time course during ex vivo balloon angioplasty [PDF]
, 1997 A relation between restenosis and arterial lesions resulting from balloon angioplasty has been suggested in literature. Nevertheless, it is unclear to what extent angioplasty-induced arterial wall lesions contribute to the occurrence of restenosis.
Boom, Herman B.K. +4 more
core +3 more sources
In Stent Restenosis Predictors after Carotid Artery Stenting
Stroke Research and Treatment, 2010 Purpose. The long-term efficacy of carotid artery stenting is debated. Predictors of stent restenosis are not fully investigated. Our aim was to assess the incidence of long term restenosis after CAS and to identify some predictors of restenosis. Methods.
Mirco Cosottini +7 more
doaj +1 more source
Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries [PDF]
, 2011 <p><b>Objective:</b> We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth ...
Baker, A.H. +10 more
core +1 more source